These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 7471515

  • 1. Lymphocyte blastogenesis in nephrotic syndrome.
    Minchin MA, Turner KJ, Bower GD.
    Clin Exp Immunol; 1980 Nov; 42(2):241-6. PubMed ID: 7471515
    [Abstract] [Full Text] [Related]

  • 2. Experimental nephrosis: interassociation of proteinuria with impaired lymphocyte blastogenesis.
    Minchin MA, Bower GD, Turner KJ.
    Clin Exp Immunol; 1981 Feb; 43(2):270-5. PubMed ID: 7273481
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Inhibitory factors of lymphocyte transformation in sera from patients with minimal change nephrotic syndrome.
    Beale MG, Hoffsten PE, Robson AM, MacDermott RP.
    Clin Nephrol; 1980 Jun; 13(6):271-6. PubMed ID: 6447569
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effect of indomethacin on lymphocyte response to mitogens in puromycin aminonucleoside nephrosis in the rat.
    Garin EH, Barratt TM.
    Clin Exp Immunol; 1982 Sep; 49(3):639-44. PubMed ID: 7172499
    [Abstract] [Full Text] [Related]

  • 7. Altered in vitro lymphocyte response in childhood nephrotic syndrome.
    Hewitt IK, House AK, Potter JM, Kinnear BF.
    Pediatr Nephrol; 1992 Sep; 6(5):464-6. PubMed ID: 1457329
    [Abstract] [Full Text] [Related]

  • 8. Impaired primary antibody response in experimental nephrotic syndrome.
    Garin EH, Sausville PJ, Richard GA.
    Clin Exp Immunol; 1983 Jun; 52(3):595-8. PubMed ID: 6347472
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Clinical impact of cyclosporine cellular pharmacodynamics in minimal change nephrotic syndrome.
    Hirano T, Akashi T, Keira T, Oka K, Ihoya N, Yoshida M.
    Clin Pharmacol Ther; 2000 Nov; 68(5):532-40. PubMed ID: 11103756
    [Abstract] [Full Text] [Related]

  • 12. [Immunologic state and effect of long-term levamisole therapy on selected immunologic parameters in children with steroid sensitive nephrotic syndrome during remission].
    Prandota J, Jankowski A, Szozda A.
    Pol Tyg Lek; 2000 Nov; 48(20-22):455-9. PubMed ID: 8170809
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effect of thymus factor and levamisole treatment in patients with persistent nephrotic syndrome.
    Czekalski S, Sulima D, Strzelecka G.
    Proc Eur Dial Transplant Assoc; 1983 Nov; 19():800-3. PubMed ID: 6603617
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. T-cell subsets and response to mitogens in patients with steroid responsive nephrotic syndrome.
    Lin CY.
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1985 Aug; 18(3):169-76. PubMed ID: 3877619
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.